Hardware, Robotics & IoT VC Funds

Decisive Point is a venture capital firm specializing in early-stage investments in deep-tech innovations, particularly those addressing critical challenges in defense, energy, infrastructure, and healthcare. Based in Beacon, New York, and with close ties to government and military sectors, Decisive Point has carved a niche in backing startups that align with U.S. national security and public sector needs. Notable portfolio companies include Pison Technology, RapidSOS, and Macro-Eyes. These firms exemplify Decisive Point’s focus on dual-use technologies—those that serve both commercial and government markets. The fund’s strategy involves not only providing capital but also offering extensive support in navigating complex government procurement processes, securing non-dilutive R&D funding, and establishing key relationships within the federal ecosystem. This approach significantly de-risks their investments by helping portfolio companies secure stable government contracts early in their growth. With a team led by founders with deep industry experience, including military veterans like Thomas Hendrix, Decisive Point is well-positioned to identify and foster groundbreaking technologies. The firm typically invests at the Seed and Series A stages, often leading the rounds and leveraging its expertise to guide startups through regulatory and acquisition hurdles. Entrepreneurs looking to partner with Decisive Point should have a clear vision for how their technology addresses a critical government need, as the firm is deeply invested in solutions that can achieve significant federal scale and impact.

DeClout Ventures is the corporate venture capital unit of DeClout Pte Ltd, incorporated in Singapore in December 2016. DeClout is a wholly owned subsidiary of Exeo Global — the Asia Pacific regional headquarters of Tokyo Stock Exchange-listed Kyowa Exeo Corporation — giving DeClout Ventures the backing of a major Japanese industrial group with deep infrastructure and ICT capabilities. The firm was awarded a S$10 million venture capital fund on a matching basis to invest in Singapore-based technology startups, with a focus on fintech, smart logistics, IoT, cybersecurity, and data analytics. DeClout Ventures leads rounds and deploys checks of $500,000 to $4.5 million from seed through Series A stages. The firm made its maiden investment of S$500,000 in Vi Dimensions, a Singapore-based video analytics company. Subsequent investments include leading a $4.5 million round in Charged Indonesia in e-mobility technology and co-leading a $7.1 million Series A for HeveaConnect, a digital natural rubber trading platform, alongside Provident Capital Partners. With 4 investments across transportation, data analytics, marketplace, and cybersecurity, the fund has maintained a concentrated and strategic deployment pace. Beyond direct investments, the broader DeClout group operates portfolio companies including GUUD in trade technology, Aeqon in ICT solutions, Ascent Solutions in IoT, and dhost in neutral hosting — creating a group-level ecosystem of complementary technology businesses. CEO Lim Swee Yong leads the fund's operations and investment strategy across Southeast Asia.

Deep Blue Ventures (DBV) is Italy's first deep tech venture capital fund focused on Rome, launched in 2023 and managed by Deep Ocean Capital SGR S.p.A. The fund closed its first tranche at EUR 40.8 million against a EUR 70 million target, backed by cornerstone investors including the European Investment Fund (EIF), CDP Venture Capital SGR, Blue Ocean Finance, and ReItaly21 — a coalition that reflects DBV's ambition to anchor Rome in the European deep tech map. The fund leads at seed stage, with selective Series A participation. DBV deploys EUR 500,000 to EUR 2.5 million per investment, targeting exponential technologies including artificial intelligence, quantum computing, photonics, cybersecurity, synthetic biology, and advanced materials applied to strategic sectors such as aerospace, healthcare, and sustainability. The portfolio of 7 investments — completed within the first 18 months of operation — includes AI4IV in neuromorphic computing, OhmSpace in aerospace, PhotonPath in semiconductor photonics, Genoa Instruments in super-resolution microscopy, and Random Power in quantum randomness. Key institutional partners include Leonardo, the European Space Agency, I3P incubator at Politecnico di Torino, the Italian Institute of Technology, and the National Research Council. DBV is led by Chairman and Co-Founder Emilia Garito, CEO and Co-Founder Domenico Nesci, and Chief Investment Officer Paolo Cellini. The firm operates a Deep Tech Factory Model that combines venture capital with venture building to accelerate the de-risking of breakthrough technologies from Italian and European research institutions into scalable commercial ventures.

Deep Science Ventures (DSV) is a London-based venture studio founded in 2016 that specializes in building science-driven startups across four key sectors: agriculture, computation, climate, and pharmaceuticals. DSV's approach is unique in that it combines scientific knowledge with entrepreneurial expertise to create high-impact ventures from scratch. They partner closely with founder-scientists to tackle some of the world's most pressing challenges, such as reversing global warming, developing curative therapeutics, and advancing computational technologies. DSV's portfolio includes a diverse range of companies, such as Mission Zero Technologies, which focuses on energy-efficient direct air capture of CO2, and Neobe Therapeutics, which is engineering bacteria to improve the efficacy of cancer immunotherapy. These ventures reflect DSV's commitment to creating transformative solutions that are both scientifically rigorous and commercially viable. The firm's model emphasizes de-risking ventures through deep technical and market analysis before significant capital is committed. This methodical approach ensures that the startups they create have a strong foundation for long-term success.

Deepbridge Capital, established in 2010 and headquartered in Chester, UK, focuses on providing growth capital to companies in the technology, life sciences, and renewable energy sectors. Their investment approach emphasizes supporting innovative and high-growth potential companies through various tax-efficient investment opportunities. Deepbridge Capital's portfolio includes a diverse array of companies. Notable investments are in firms like AlgaeCytes, which specializes in producing high-quality EPA oils from algae, and VoxSmart, which provides compliance management solutions for banks. They have also invested in promising startups like Thalia Design Automation, an AI-driven EDA platform, and Ibis Vision, a cloud-based vision testing software for the optical industry. The firm has made 168 investments and has seen 101 exits, showcasing their experience and success in nurturing companies to achieve significant milestones. Deepbridge Capital also supports companies through initiatives such as the Deepbridge Technology Growth EIS Fund and the Deepbridge Innovation SEIS Fund, offering financial backing and strategic guidance to early-stage businesses. The Deepbridge team, led by Managing Partner Ian Warwick, is known for their commitment to fostering innovation and growth across their investment sectors. For more information about their investments and strategic approach, you can visit their official website.

The DeepTech & Climate Fonds (DTCF) is a German venture capital fund aimed at supporting growth-stage startups working on transformative technologies in sectors such as deep tech and climate tech. Established in 2023, the fund has a capital pool of €1 billion, sourced from Germany’s Future Fund and the European Recovery Program. It focuses on companies developing solutions in fields like Industry 4.0, quantum computing, AI, and clean energy technologies. DTCF primarily invests in companies that require long development cycles and substantial capital, providing them with the resources to scale their innovations across Europe. The fund works as an anchor investor, partnering with institutional investors, family offices, and private capital to ensure that these companies can achieve commercial success and contribute to a climate-neutral economy. Led by Dr. Elisabeth Schrey and Tobias Faupel, DTCF has already made notable investments in companies like Membion, which focuses on wastewater recycling, and Cylib, a battery recycling startup. The fund's mission is to drive systemic change by investing in technologies that will reshape industries and contribute to sustainability across the European tech landscape​.

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Defy Ventures, a New York-based venture capital firm founded in 2010 by Catherine Hoke, focuses on early-stage investments and supporting entrepreneurs, particularly those with unconventional backgrounds such as former convicts. The firm is dedicated to fostering entrepreneurship, employment, and character training for its community. Defy's portfolio includes notable companies such as Nautilus Biotechnology, Empower, and Shujinko. They have made significant investments in various sectors, including high tech, business services, and food and agriculture tech. Recent investments include Monitaur, Writ, and Delivery Collective. The firm values authenticity and the tenacity needed to transform bold ideas into lasting companies. Defy Ventures aims to be the partner of choice for today's daring startup founders, helping them become tomorrow's visionary leaders. They emphasize working behind the scenes to amplify the success of their portfolio companies.

Delin Ventures is a UK-based, mission-driven venture capital firm that focuses on early-stage investments, specializing in two key areas: Life Sciences and the Future of Work & Learning. Established in 2015, the firm backs founders working on breakthrough technologies that can transform healthcare through cell therapies and the future of human work and learning. Delin invests in pre-seed and seed rounds, with typical ticket sizes ranging from €100,000 to €1.5 million, primarily in European startups. In the Life Sciences domain, Delin is committed to advancing cell therapy solutions that can either cure life-threatening diseases or transform them into manageable, chronic conditions. They also invest in the infrastructure necessary for the development and commercialization of these therapies. Notable investments include startups working on innovative therapeutics, medical services, and manufacturing technologies. In the Future of Work & Learning sector, Delin Ventures aims to unlock human potential by investing in technologies that shape the workforce of tomorrow. This includes HR tech, productivity tools, workforce development, and upskilling platforms. They provide hands-on support to founders, leveraging their deep operational expertise and extensive network. The team, led by founder Igor Linshits, includes experts from various industries, ensuring a strong focus on long-term impact. Delin's strategy is centered around making fewer, high-quality investments to ensure that they can offer exceptional support to their portfolio companies, which includes businesses like Fluidic Analytics, Vidsy, and Ori Biotech. The firm is highly selective, providing patient capital and working closely with founders to scale impactful solutions.

Dell Technologies Capital (DTC) is the venture capital investment arm of Dell Technologies, focusing on early-stage investments in the enterprise technology space. Since its inception in 2012, DTC has invested in over 150 companies, helping to propel innovations in data and analytics, cybersecurity, infrastructure, developer tools, and silicon. Their notable portfolio includes industry leaders like DocuSign, MongoDB, and Cylance​. DTC’s investment strategy is to partner with founders from the early stages and provide not only capital but also deep domain expertise and operational support. The firm’s extensive network within Dell Technologies offers startups real customer connections and the opportunity to scale with the backing of a tech giant. Investments typically range from seed to growth stages, with DTC often leading the rounds​. Headquartered in Palo Alto, California, DTC’s team of investors, technologists, and operators work closely with portfolio companies, guiding them from inception to market leadership. This hands-on approach ensures that the startups benefit from strategic insights and operational know-how, positioning them for successful exits​​. Overall, Dell Technologies Capital stands out for its commitment to fostering groundbreaking enterprise technologies and its robust support system for startups aiming to disrupt the tech landscape.

Delphi Ventures, founded in 1988, is a venture capital firm based in San Mateo, California. The firm focuses primarily on life sciences, including biotechnology, medical devices, and healthcare IT. Over the years, Delphi Ventures has made significant contributions to the life sciences industry with over 318 investments and 190 exits. Notable investments by Delphi Ventures include Revance Therapeutics, Senseonics, and PTC Therapeutics. These companies have developed innovative solutions in neurotoxin aesthetics, continuous glucose monitoring, and treatments for rare diseases, respectively. Revance Therapeutics, for instance, is now a public company with significant revenue, reflecting Delphi Ventures' ability to identify and nurture high-potential startups. Delphi Ventures' investment strategy is centered on early and growth-stage investments, with a focus on supporting pioneering technologies and therapies. The firm has a strong track record of successful exits, including companies that have gone public such as EBR Systems and Senseonics, as well as several notable acquisitions like Seattle Genetics and Acclarent. The team at Delphi Ventures is led by experienced professionals such as Deepa Pakianathan, Douglas Roeder, and founder James Bochnowski. Their expertise and deep industry knowledge play a critical role in guiding portfolio companies toward successful growth and market leadership.

Delta Partners is a Dublin-based venture capital firm specializing in early-stage investments in technology companies. Founded in 1994, the firm has a strong track record with over 140 investments and €1.8 billion in exit returns. Delta Partners focuses on seed and Series A investments, supporting companies from their foundation stage through to successful scaling and exits. They emphasize building solid company foundations and capital-optimizing cultures to increase the likelihood of success. The Delta team includes experienced partners like Dermot Berkery, Maurice Roche, Amy Neale (formerly of Mastercard), and Richard Barnwell (founder of Digit Games). They are committed to integrating sustainability risks into their investment process, ensuring that environmental, social, and governance (ESG) factors are considered throughout the lifecycle of their investments. Delta Partners operates with a partner-led approach, providing startups with direct access to senior-level experience from the first conversation. This hands-on support helps entrepreneurs navigate their journey from seed to Series A and beyond.

Demeter, a major European player in venture capital, private equity, and infrastructure, focuses on investments that drive the energy and ecological transition. Founded in 2005, Demeter manages €1.3 billion across its funds and has completed over 230 investments. The firm targets innovative startups, SMEs, and infrastructure projects, offering investments ranging from €1 million to €30 million. Notable investments include McPhy Energy, which specializes in hydrogen production, storage, and distribution technologies, and Ynsect, which produces environmentally friendly insect-based products. Demeter also supports companies like Sunna Design, which develops solar LED lighting solutions, and Sweetch Energy, a renewable energy firm focusing on osmotic energy. One of Demeter's significant initiatives is the recent launch of a €500 million fund in collaboration with EIT InnoEnergy. This fund aims to develop a resilient and diverse battery raw material supply chain for Europe, addressing the continent's growing demand for batteries and supporting the European Battery Alliance's goals. Demeter's investment strategy is driven by a commitment to sustainability, evident in their support for green projects like H2 Green Steel, the world's first integrated large-scale green steel plant. The firm's dedication to environmental responsibility is further reflected in their involvement in initiatives like the Climate Dividends program, which promotes sustainability across their portfolio companies.

Derayah Ventures is a Saudi-based venture capital firm that invests in early to growth-stage startups across the MENA region. Launched in 2019, the firm manages a $30 million fund focused on technology-driven businesses, particularly in sectors such as SaaS, fintech, eCommerce, artificial intelligence, Internet of Things (IoT), and marketplace platforms. Derayah primarily backs companies that are either disrupting traditional industries or organizing them through innovative solutions. The firm’s investment philosophy centers on supporting scalable startups with high growth potential and strong teams. Derayah Venture Capital provides not just financial backing but also strategic guidance to help companies expand within the MENA region, especially into Saudi Arabia. The fund focuses on post-seed, pre-Series A, and Series A stages, enabling startups to access critical capital during their early development phases. Led by a team of experienced investors, including Chairman Faris Ibrahim AlRashed, Derayah aims to build tomorrow's market leaders through a combination of capital, industry expertise, and strong local networks.

Detroit Venture Partners (DVP), founded in 2010 by Dan Gilbert, is a venture capital firm committed to backing early-stage tech startups that aim to drive innovation and economic growth. Based in Detroit, DVP is part of the broader Rock Family of Companies, which includes Rocket Companies, Bedrock Detroit, and the Cleveland Cavaliers. This extensive network enables DVP to offer its portfolio companies not only financial backing but also strategic partnerships and resources to help them scale effectively. DVP focuses on investing in startups that embody creativity, grit, and passion. They have a strong emphasis on companies in the technology sector, including fintech, SaaS, and logistics. Some of their notable portfolio companies include StockX, Livegistics, 100 Thieves, and CoverTree. By fostering innovation, DVP contributes to Detroit’s entrepreneurial ecosystem, helping to rejuvenate the city’s long history of industrial innovation. In addition to their investment activities, DVP runs a Summer Fellowship program that offers MBA and undergraduate students hands-on experience in venture capital and early-stage startups.

Beyond1435 is Deutsche Bahn's venture capital initiative that focuses on fostering innovation in the transportation and mobility sectors. Emerging from DB Digital Ventures in 2016, Beyond1435 has established itself as a key player in driving the future of rail and mobility technologies. The platform is dedicated to identifying and investing in early-stage startups that offer transformative solutions in areas like sustainability, production, and digital services. The firm partners with startups to develop technologies that align with Deutsche Bahn’s long-term goals of modernizing rail transport and enhancing operational efficiency. Beyond1435 supports startups through investment, collaboration, and access to Deutsche Bahn’s extensive global network. The firm focuses on technologies related to artificial intelligence, IoT, mobility, and smart cities. By fostering collaborations with external companies and setting up joint ventures, Beyond1435 strengthens not only Deutsche Bahn but also the wider mobility ecosystem. Its broad portfolio includes companies such as Brighter AI, Gideon Brothers, and Skyports, reflecting its commitment to advancing innovative technologies across sectors.

DTCP (Digital Transformation Capital Partners) is an independent investment management firm founded in 2015. The firm focuses on two main investment strategies: Growth Equity and Digital Infrastructure. With over €2.2 billion in assets under management, DTCP has invested in more than 60 companies, supporting transformative technology leaders globally and digital infrastructure projects in Europe. DTCP's Growth Equity platform targets technology sectors such as cybersecurity, AI, fintech, and cloud-based enterprise software, aiming to accelerate digital transformation. Their notable portfolio includes investments in companies like Aryaka, NS1, and Heap. The firm’s data-driven investment approach and strong operational support help these companies scale effectively. In the Digital Infrastructure space, DTCP invests in mobile towers, fiber networks, and data centers. Key infrastructure investments include Swiss Towers, Community Fibre Limited, and Cellnex Netherlands. This strategy focuses on creating long-term value and supporting sustainable digital infrastructure development across Europe. The leadership team is headed by CEO Vicente Vento and includes Managing Partner Jack Young, who oversees the Growth platform, and Philipp von Bismarck, Managing Partner for the Digital Infrastructure Vehicle II. They bring extensive experience in technology investments and digital infrastructure projects. DTCP’s approach combines strategic capital investment with operational expertise, leveraging a strong network of industry relationships to drive growth and innovation in its portfolio companies.

Development Capital, established in 2013 and headquartered in Dublin, is an Irish growth capital fund manager focused on scaling mid-sized, profitable Irish SMEs with strong export potential. The firm typically invests between €2 million and €12 million in ambitious companies, using flexible financing structures such as equity, quasi-equity, or debt, and typically holds minority stakes with a five-year investment horizon. Development Capital is committed to supporting companies with growth strategies, ranging from international expansions to strategic acquisitions and production capacity increases. The fund’s €75 million Fund II, supported by the European Investment Fund and the Ireland Strategic Investment Fund, targets Irish SMEs poised for international growth. Notable portfolio companies include Version 1, a leading IT services provider, and Spotlight Oral Care, a premium oral care brand. Through their investments, Development Capital has helped companies like Perigord expand globally and develop new products. Perigord, a leader in life sciences packaging, was acquired by Tech Mahindra, allowing Development Capital to successfully exit its investment. The firm prides itself on offering more than just capital. It partners closely with management teams to maximize growth potential, bringing industry experience and market insights to every engagement. With a focus on responsible investing, Development Capital integrates ESG factors throughout its investment process, ensuring sustainable and impactful growth for its portfolio companies.

Devlabs is a micro venture capital firm with a focus on early-stage investments in North America, South America, and the Caribbean. Established in 2013 and headquartered in Oakland, California, and Temuco, Chile, Devlabs manages an $8 million fund dedicated to pre-seed investments in software startups, with plans to close a $21 million fund for agriculture and renewable energy sectors​. The firm typically invests between $100,000 and $300,000 per company in exchange for 5-15% equity, targeting industries such as B2B software in agri-business, finance, health, tourism, education, and operations​. Devlabs focuses on high-impact, high-growth tech entrepreneurs, especially those addressing multi-billion dollar problems with market-driven solutions. Devlabs was co-founded by Jose D Lopez and Ruben Hernandez, both of whom bring over 20 years of experience in venture capital, software development, and business innovation​ (devlabs)​. The firm leverages its extensive network and experience in emerging markets to reduce barriers and costs for investment, aiming to support lean, early-stage companies and help them scale rapidly.

DG Daiwa Ventures, a Tokyo-based venture capital firm founded in 2016, is a joint venture between Digital Garage and Daiwa Securities Group. The fund focuses on early-stage investments in cutting-edge technologies, such as blockchain, artificial intelligence (AI), cybersecurity, biohealth, and extended reality (xR). DG Daiwa Ventures operates globally, with a special emphasis on startups in Japan and the broader Asia-Pacific region. The firm manages two main funds: DG Lab Fund I and DG Lab Fund II, which collectively manage over 20 billion yen. These funds target high-potential tech startups by leveraging the combined expertise and incubation capabilities of both Digital Garage and Daiwa Securities. DG Daiwa Ventures has a track record of nurturing successful startups, such as Goodpatch and Akili Interactive Labs, which have gained recognition for their innovative products. DG Daiwa is known for supporting its portfolio companies with strategic resources and helping them scale through partnerships, additional fundraising, and IPO support. The firm aims to identify companies that can drive technological advancements and create substantial returns for investors through a global network of partners and later-stage investors.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

Diamond Capital is a venture capital firm based in Taiwan, primarily focusing on investments in the biotechnology, medical, and high-tech sectors. Established in 2013, the firm has built a strong reputation for nurturing innovative companies that are driving advancements in healthcare, new drug development, high-end medical equipment, and innovative medical services. Diamond Capital is known for its strategic investments that span early to growth-stage companies, particularly those operating in Asia. The firm is particularly noted for its involvement in the biotechnology sector, where it has been instrumental in supporting startups that have gone on to achieve significant milestones, including public listings. Diamond Capital's strategy involves not only providing capital but also leveraging its extensive network and expertise to guide companies through the complexities of scaling and entering global markets. This approach has made it a key player in Taiwan’s venture capital landscape. In 2023, Diamond Capital made headlines by becoming the first biotech venture capital firm to list on the Taiwan Stock Exchange, further enhancing its visibility and credibility on the international stage. The firm's portfolio includes a diverse array of companies, from cutting-edge biotech firms to innovative medical device manufacturers, all of which are united by their potential to make significant contributions to their respective fields.

DIC Corporation operates a Corporate Venture Capital (CVC) unit that focuses on strategic investments aligned with their core mission of sustainable innovation. Founded as a global leader in fine chemicals, DIC leverages its venture capital arm to support startups that bring new, disruptive technologies in areas like biomanufacturing, advanced materials, and industrial IT. Their investment strategy aims to complement their existing businesses in sectors such as color science, healthcare, and packaging. Recent notable investments include funding Debut Biotechnology, a California-based company specializing in sustainable biomanufacturing. This partnership allows DIC to accelerate the development of bio-based materials, particularly natural pigments for cosmetics and nutrition, aligning with their long-term vision of sustainability under the DIC Vision 2030 plan. DIC's CVC activities also extend to partnerships with other venture funds, such as their collaboration with Emerald Technology Ventures, which focuses on industrial innovation in clean technology. DIC’s strategic approach to venture investing helps them explore new markets while enhancing their capabilities in sustainable products, driving innovation across their global network of over 190 companies.

Diehl Ventures GmbH is a corporate venture capital subsidiary of the Diehl Group, a German industrial conglomerate. Founded in December 2015 and headquartered in Nuremberg, Germany, Diehl Ventures invests in technology-driven startups with growth potential aligned with the Diehl Group's five divisions: Metall, Controls, Defence, Aviation, and Metering. Managing Director Mathias Glasmacher leads the operation, which coordinates closely with the parent company's operative business units to create industrial synergies. The firm has executed more than 20 deals at Seed and Series A stages, writing checks between $250,000 and $5 million. Diehl Ventures focuses on nine technology themes including materials and production technologies, energy storage and conversion, IoT, cybersecurity, data analysis, aircraft cabin technologies, and platform-based business models. Portfolio companies include Walaris (AI-powered drone detection and airspace security), Symvaro (smart city and digital water economy), Rockethome (energy IoT and smart home solutions), and Auterion (drone and robotics software platform). As a strategic investor, Diehl Ventures gives portfolio companies access to the Diehl Group's extensive network of industrial customers and suppliers, offering commercial validation opportunities that are particularly valuable for deep tech and hardware-oriented startups. The firm focuses primarily on European companies, with particular emphasis on the German market, and aims to find opportunities where the parent group's domain expertise translates into measurable competitive advantage for the investee.

Differential Ventures is a seed-stage venture capital fund founded by data scientists and entrepreneurs, with a focus on investing in B2B, data-centric technology startups. Notable investments include companies like Private AI, Ocrolus, and Agnostiq, which are at the forefront of AI, machine learning, and quantum computing. The fund primarily targets enterprises that leverage data to transform business operations, with significant investments in AI-powered business solutions, cybersecurity, and fintech. Geographically, Differential Ventures is based in New York but maintains a broad investment horizon, with portfolio companies spread across North America. Their strategy emphasizes early-stage investments, typically writing checks between $250,000 and $1 million, and they often lead funding rounds. The firm is proactive in offering guidance to portfolio companies, drawing on their deep expertise in data science and entrepreneurial ventures. Key team members include Nick Adams, co-founder and managing partner, known for his hands-on approach and operational insights, and David Magerman, a managing partner who brings extensive experience in AI and machine learning operations. Differential Ventures is known for its active involvement in the tech community, hosting webinars and engaging in discussions about AI policy and its implications for industry and society. For startups seeking investment, approaching Differential Ventures with a well-defined data-driven strategy and a scalable business model is crucial.

DCP Capital is a private equity firm based in Beijing, China, founded in 2017 by Julian Wolhardt and David Liu. The firm focuses on investments in companies operating in sectors such as healthcare devices, semiconductors, commercial services, agriculture, and manufacturing across Mainland China, Hong Kong, Macau, and Taiwan. Notable investments by DCP Capital include Jamieson Wellness, a leading consumer health brand; Mengniu Dairy, one of China’s largest dairy producers; and 51job, a major recruitment website in China, which was acquired for $3.8 billion. The firm has also invested in innovative companies like Broncus Medical, Venus MedTech, and Fenbi, which focuses on education and training services. DCP Capital manages assets of over $2.5 billion, having recently completed the first close of their second China fund. This fund aims to invest in early and growth-stage companies, furthering their mission to support transformative businesses in the region.

Digital Currency Group (DCG), founded in 2015 by Barry Silbert, is a prominent venture capital firm dedicated to accelerating the development of a better financial system through investments in blockchain and digital currency companies. With over 200 equity investments in more than 30 countries, DCG has established itself as the most active investor in the digital asset industry. DCG owns and operates several leading businesses within the crypto ecosystem. These include CoinDesk, a top media, research, and events platform; Genesis, a major institutional lending and brokerage firm; Grayscale Investments, the largest digital currency asset management firm; Foundry, which focuses on digital asset mining and staking; and Luno, a global digital asset exchange and wallet provider​. Their investment strategy encompasses a broad array of sectors such as payments, privacy, stablecoins, trading tools, Web3 infrastructure, DeFi, and NFTs, among others. DCG supports companies at various stages of development, from seed and venture to growth and public markets, ensuring comprehensive support through all phases of their growth​.

Digital Leaders Ventures (DLV) is a European venture capital fund founded in 2014 and headquartered in Luxembourg, operating as a fully registered alternative investment fund manager and AIF. The firm was founded by Monty C. M. Metzger, a serial entrepreneur and digital futurist, and Thomas S. Enge, a financial executive and former CFO at simyo and amaysim. DLV invests through its Ignition Fund in fast-growth tech companies with scalable business models, targeting startups that have working products, early customers, and initial revenues — typically post-accelerator or post-seed stage. With 8 investments to date, DLV writes checks of $100,000 to $1 million at Seed and Series A. The fund focuses on six key sectors: Smart Cities, Education, Healthcare, Finance including blockchain, Communication, and Mobility and Industry 4.0. Portfolio companies include Aircall (cloud-based phone systems), PayKey (mobile banking via social keyboards), Cortrium (cardiac monitoring), Revue (newsletter platform acquired by Twitter), and VOIQ. Co-investors have included Balderton Capital, Greylock Partners, Y Combinator, and 500 Startups. DLV leverages its global network through DigitalLeaders.co to support founders scaling internationally, with portfolio companies headquartered across the USA, Israel, Denmark, France, and the UK. The firm also maintains a syndicate on AngelList, broadening its deal access and co-investment capacity across the European and global tech landscape.

Digitalis Ventures is a venture capital firm established in 2016, focused on investing in innovative solutions within the realms of human and animal health. Headquartered in New York, with offices in Boston, Los Angeles, San Diego, San Francisco, and Gainesville, the firm leverages deep technical, financial, and domain expertise to support early-stage companies. Digitalis Ventures’ portfolio includes companies like Expressable, Elegen, and Alterome Therapeutics, reflecting their interest in biotechnology, health technologies, and services. Notable exits include Scout Bio and PetMedix. The firm typically leads investment rounds, providing substantial capital and strategic guidance to help startups scale. The investment strategy centers around life sciences, health technologies, and animal health. They invest in companies developing breakthrough technologies in therapeutics, diagnostics, and tools that improve healthcare access, outcomes, and efficiency. Their Companion Fund specifically focuses on advancing animal health. Key team members include founder Geoffrey Smith and partners such as Amit Bansal and Drew Taylor, who bring extensive experience in venture investing and health technologies.

firm focuses on investing in early-stage companies within the digital health sector, aiming to address significant challenges and inefficiencies in healthcare. Their investment strategy centers on data-driven technologies that can revolutionize healthcare and improve patient outcomes through innovative solutions in personalized medicine, data analytics, and digital therapeutics. DigiTx Partners is notable for backing companies like Eko, which develops diagnostic devices for heart and lung diseases, and Rune Labs, which focuses on precision neurology through software and data analytics. Their portfolio also includes Cleerly, specializing in cardiovascular disease diagnostics, and Savonix, which offers cognitive function management systems. The firm was created as a joint venture between Astellas Pharma and MPM Capital, and it raised $75 million for its Rx Digital Fund in 2018. This fund supports seed and Series A-stage companies that are developing healthcare and life sciences technology utilizing data​. Key team members include Managing Director David Kim, MD, and Partner & Principal Miraj Sanghvi, who bring substantial expertise in healthcare and investment management.

Digital Horizon is a forward-thinking venture capital firm that backs entrepreneurs at every stage of their journey, focusing on fintech, SaaS, and AI startups. They have a notable portfolio including Klarna, Lemonade, Monday.com, Ably, and Bolt, showcasing their knack for identifying high-potential ventures. Founded by Alan Vaksman, Digital Horizon leverages a global network with a presence in London, Tel Aviv, and Dubai, emphasizing support for immigrant founders and diverse teams. Their investment strategy is unique, employing a multi-stage approach that spans from early-stage to later-stage investments, ensuring high returns and liquidity. This method has proven successful, with their first fund achieving an impressive 40% annual return. They prioritize startups solving real-world problems with a clear path to profitability, even if immediate profitability isn’t required. Digital Horizon is actively expanding into the Middle East, with a focus on Dubai and the broader MENA region. They target sectors like e-commerce, digital payments, crypto infrastructure, and B2B solutions. Founders looking for investment should be prepared to demonstrate strong problem-solving capabilities and a solid economic model. Key team members include Helena Haykin, Rohit Mathur, Vlad Tropko, and Levy Raiz, who bring extensive experience from major corporations and startups globally. For entrepreneurs seeking to connect, Digital Horizon values clear, impactful pitches that align with their mission to foster innovation and scalable growth.

DN Capital, founded in 2000, is a global early-stage venture capital firm with offices in London, Berlin, and San Francisco. They focus on Seed, Series A, and select Series B opportunities across Europe and North America. The firm specializes in sectors such as fintech, SaaS, digital media, marketplaces, and consumer internet. Some of DN Capital's notable investments include Shazam, Auto1, OLX, Purplebricks, and GoStudent. These investments showcase DN Capital's knack for identifying and supporting companies that can scale globally. They have managed over $1 billion in assets and achieved numerous successful exits, including acquisitions by major corporations such as Apple (Shazam) and Oracle (Endeca)​. The firm is led by founders Nenad Marovac and Steve Schlenker, who bring deep entrepreneurial and financial expertise. DN Capital emphasizes a hands-on approach, providing portfolio companies with strategic guidance, business development opportunities, and extensive network connections. Their commitment to openness and integrity, combined with rigorous investment practices, makes them a strong partner for ambitious entrepreneurs

DNS Capital is the investment office for Gigi Pritzker and her husband Michael Pucker, based in Chicago. Founded in 2014, DNS Capital invests across various stages and industries, emphasizing long-term partnerships and strategic growth. The firm has a diverse portfolio with significant investments in technology, healthcare, and industrial sectors. Notable investments include Hero Bread, which focuses on producing low-carb bakery products; IMIDomics, a biotech company working on therapeutics for immune-mediated inflammatory diseases; and Jetti Resources, which has developed a novel technology for metal extraction from ores. Other key investments include Recogni, a company specializing in high-performance computer chips for autonomous vehicles, and PayNearMe, a platform enhancing payment experiences for businesses and their customers​​. DNS Capital's approach combines financial support with strategic guidance, leveraging the deep expertise of its leadership team. They focus on building strong relationships with business owners and management teams to drive sustainable growth and innovation across their portfolio companies​.

DNX Ventures is an early-stage venture capital firm specializing in B2B startups, with a particular focus on SaaS, cybersecurity, fintech, deep tech, sustainability, and retail tech sectors. Founded in 2011, DNX Ventures operates from offices in Silicon Valley and Tokyo, bridging two of the world's most innovative markets. The firm invests in seed and Series A startups, typically providing initial investments ranging from $1 to $5 million. DNX Ventures aims to support founders who are tackling significant challenges for enterprise companies, helping them shape industries and transform the way we live and work. Notable investments by DNX Ventures include Cylance, ICEYE, Movandi, and Nauto. Their approach emphasizes close partnership with portfolio companies, offering extensive support and resources to help them succeed.

Energy Capital Ventures is a U.S.-based fund primarily focused on driving innovation within the energy sector, especially targeting solutions that promote carbon neutrality. The firm is deeply committed to supporting startups that are developing clean energy technologies, with a strong emphasis on "green molecules" innovation—technologies that can transition gas systems to be carbon-neutral by 2050. Their geographic focus is predominantly on North America, but they maintain partnerships with global players in the energy industry. Notable investments include Cemvita, a leader in biomanufacturing for carbon-neutral processes. The fund partners closely with industry giants such as NiSource and Spire, helping their portfolio companies leverage these relationships for strategic growth. They invest primarily at the seed and Series A stages, with check sizes ranging between $500K and $3M. Energy Capital Ventures takes an active approach to investments, often leading rounds and playing a hands-on role in helping startups scale. They prioritize partnerships with entrepreneurs that align with their mission to advance clean, reliable, and affordable energy. Co-founded by veterans with decades of experience in both venture capital and energy markets, the team brings substantial expertise in utility investment banking and strategic corporate developmentю

Stichting DOEN, founded by the Nationale Postcode Loterij, supports pioneering initiatives aimed at creating a green, socially inclusive, and creative society. Based in the Netherlands, the foundation provides grants, loans, and investment capital to over 250 innovative projects each year. DOEN focuses on three main themes. First, the Regenerative Economy, supporting entrepreneurs and initiatives that work on landscape restoration, regenerative agriculture, and sustainable use of natural materials. Second, Social Solidarity, promoting inclusive societies through social enterprises and community projects that offer socioeconomic security and resilience. Third, the Power of Imagination, funding arts and cultural projects that encourage alternative perspectives and radical imagination to envision a better world. DOEN Participaties, the foundation's investment arm, targets sustainable and social startups, such as Fairphone and Bboxx, promoting impact in areas like renewable energy, circular economy, and social inclusion. DOEN receives funding from the Nationale Postcode Loterij and the VriendenLoterij, channeling these resources to drive impactful social and environmental change.

Dolby Family Ventures is a San Francisco-based venture capital firm founded in 2014 by David Dolby, investing in early-stage companies tackling frontier science and engineering challenges. Unaffiliated with Dolby Laboratories, the firm manages approximately $196 million in assets under management. The 16-person team is led by David Dolby as CEO, Senior Managing Director Pascal Levensohn, and Managing Director Andrew Krowne, supported by a distinguished Scientific Advisory Board. With 106 investments and a strong exit track record of 6 IPOs and 17 acquisitions, Dolby Family Ventures leads rounds across pre-seed, seed, and Series A with checks from $1 million to $25 million. The five core verticals are precision neuroscience (neurodegeneration, psychiatry, neurotech), life sciences platforms (regenerative medicine, computational biology), climate tech, aerospace, and digital deep tech. Portfolio companies include Motif Neurotech, Therini Bio, Ursa Major Technologies, Twelve, Paradromics, Bionaut Labs, and DigiLens. IPO exits include Athira Pharma, Eargo, Cognition Therapeutics, and Tempo Automation; acquisition exits include August (by Assa Abloy), Wickr (by Amazon), and Eyefluence (by Google). The firm takes a long-term collaborative approach, partnering with best-in-class innovators and syndicate partners to build transformative technology companies. Its willingness to back science-forward ventures at the earliest stages — often where commercial validation is years away — and the depth of the Scientific Advisory Board distinguish DFV from generalist firms operating across the same broad technology sectors.

Domain Capital Group, founded in 1985, specializes in biotechnology investments, managing a substantial $2.8 billion in assets. They have funded 194 companies in the biopharma, medical device, and diagnostic sectors, resulting in 90 IPOs and 110 M&A events. Notable companies in their portfolio include Zipline, GitLab, and DigitalOcean. Domain Capital’s strategy focuses on long-term partnerships and a diversified asset approach, investing in real estate, natural resources, media, entertainment, technology, and special situations to achieve stable, cash-on-cash returns. They operate globally with a team led by seasoned partners like James Blair and Brian Halak. Their investment process involves rigorous due diligence, strategic transaction structuring, and active asset management to ensure value creation and capital preservation. Domain Capital typically engages in growth and late-stage investments, leveraging their extensive industry experience and strong relationships to source and manage deals effectively. The firm’s hands-on approach includes personalized investor engagement, aiming to meet specific investment goals such as targeted returns and risk mitigation. This comprehensive strategy positions Domain Capital as a trusted partner for public and private pension plans, corporations, foundations, endowments, and high-net-worth individuals.

Doral Energy-Tech Ventures is the corporate venture capital arm of Doral Group, a leading global renewable energy company based in Israel. Founded in 2021, Doral Energy-Tech Ventures focuses on investing in early-stage companies that are developing innovative technologies in renewable energy and cleantech sectors, including solar and wind technologies, energy storage, smart grids, hydrogen, and water technologies. The fund supports startups by providing not just financial backing but also strategic guidance, access to Doral’s technological capabilities, and a vast network of opportunities to help them scale and succeed in the global market. Their portfolio includes companies like Yotta Energy, OxCCU, and Phinergy, which are making significant strides in areas like energy storage and hydrogen technology. Led by Roee Furman as Managing Director and Guy Yavin as Investment Director, Doral Energy-Tech Ventures emphasizes a collaborative approach, partnering closely with entrepreneurs to address global sustainability challenges and drive impactful innovations.

Dorm Room Fund (DRF), founded in 2012 by Josh Kopelman under the auspices of First Round Capital, is a venture capital firm that focuses on investing in student-run startups. Headquartered in Cambridge, Massachusetts, DRF has made over 400 investments and has achieved 145 exits. Notable exits include MetaMap, DiscreetAI, WorkerSense, and ScienceIO. DRF’s mission is to support student founders by providing access to a powerful investor network, world-class mentors, and essential capital to accelerate their growth. The fund has supported over 300 companies led by student founders, including prominent names like Athelas and WellTheory. Dorm Room Fund is dedicated to promoting diversity, equity, and inclusion within the venture capital industry. Nearly 80% of their alumni go on to become founders or venture capitalists themselves. The fund has created initiatives like the Blueprint Project and the Female Founder Track to empower underrepresented students. The investment team at DRF consists of student partners who bring unique insights into the next wave of groundbreaking companies. This model allows them to identify promising startups that might be overlooked by traditional investors.

Dow Venture Capital, a corporate venture arm of Dow Inc., focuses on strategic investments that align with Dow's broader goals of sustainability and innovation. Established in 1994, the unit is headquartered in Midland, Michigan, and targets a range of sectors including clean technology, advanced materials, recycling, and healthcare. Their investments often seek to advance circular economy solutions, such as their partnerships with companies like Plastogaz, which aims to simplify plastic recycling processes through advanced catalytic technology, and Mura Technology, which focuses on chemical recycling for hard-to-recycle plastics. Dow Venture Capital also collaborates with companies in the fields of renewable energy, water treatment, and sustainable agriculture, demonstrating their commitment to tackling global environmental challenges. With a presence across North America, Europe, and Asia, their approach blends Dow’s extensive materials science expertise with innovative startup technologies, facilitating solutions that can scale globally. Dow's focus on recycling has led to investments that aim to close the loop on plastic waste, ensuring materials can be reused sustainably​. Overall, Dow Venture Capital plays a key role in Dow’s strategic direction by supporting startups that drive growth and value, particularly in areas that complement their sustainability mission and core business sectors.

DRADS Capital is a Boston-based venture capital firm focused on investing in groundbreaking innovations within the life sciences, biotechnology, and artificial intelligence sectors. The firm is driven by a mission to back visionary entrepreneurs who are pushing the boundaries of science and technology to create a healthier future. DRADS Capital targets early to late-stage companies that offer transformative solutions to some of the world's most challenging health problems. Founded by A. Nagarajan Pillay, a seasoned entrepreneur with over 25 years of experience, DRADS Capital has built a diverse portfolio that includes companies specializing in areas such as organ regeneration, precision fermentation, and AI-driven healthcare solutions. The firm is known for its hands-on approach, working closely with startups to navigate the complexities of bringing innovative healthcare products to market. DRADS Capital operates with a small, tight-knit team of experts who are deeply involved in every aspect of the investment process. This team includes professionals with backgrounds in law, venture capital, and global business development, all contributing to the firm's strategic vision.

Dragonfly Capital, founded in 2018, is a global venture capital firm with a strong focus on cryptocurrency and blockchain technology. With headquarters in San Francisco, Dragonfly has rapidly become a key player in the crypto space, supporting startups and projects that push the boundaries of decentralized finance (DeFi), blockchain infrastructure, and emerging consumer crypto products like NFTs and decentralized autonomous organizations (DAOs). The firm recently closed its third venture fund at $650 million, surpassing its initial target of $500 million. This new fund enables Dragonfly to invest across all stages of development, from seed funding to later-stage growth, helping build "generational companies" in crypto. Notable portfolio investments include projects like Aptos, Bybit, and Celo, which span sectors from layer-one blockchain protocols to NFT platforms. Led by managing partner Haseeb Qureshi, Dragonfly works closely with founders across the globe, combining deep technical expertise and market knowledge to help teams scale. Their global reach and focus on collaboration with the best crypto-native founders have positioned them as a leading venture fund in the rapidly evolving blockchain ecosystem​.

Draper Associates, founded in 1985 by Tim Draper, is a renowned early-stage venture capital firm based in Silicon Valley. The firm has made significant investments in transformative companies across various sectors, including technology, consumer services, and financial services. Draper Associates is known for its notable investments in companies like Hotmail, Skype, Tesla, SpaceX, Twitch, Robinhood, Coinbase, and Baidu. The firm focuses on backing innovative startups with the potential for extraordinary outcomes, often investing at the seed stage and supporting companies through their growth journeys. Draper Associates prides itself on being entrepreneur-friendly, providing extensive support and resources to help founders succeed. Draper Associates is part of the larger Draper Ecosystem, which includes Draper University, Draper Venture Network, and Draper Startup House, among other initiatives aimed at fostering entrepreneurial growth and innovation globally. The firm's investment philosophy emphasizes a global perspective, investing in industry-transforming companies across the world while maintaining a strong presence in Silicon Valley. Draper Associates continues to innovate and drive significant impact in the venture capital landscape by backing visionary entrepreneurs and leveraging its extensive network and resources.

Draper Dragon is a venture capital firm that specializes in investing in early-stage startups with a focus on technological innovation and cross-border opportunities between the U.S. and Asia, particularly China. As part of the larger Draper Venture Network, Draper Dragon leverages its global presence and network to help entrepreneurs scale their businesses and expand into international markets. The firm primarily invests in cutting-edge industries such as blockchain, artificial intelligence (AI), fintech, healthcare, and enterprise software. Founded in 2006, Draper Dragon stands out for its ability to bridge the gap between Silicon Valley and Asia’s rapidly growing tech ecosystems. The firm provides more than just capital; it offers strategic guidance, access to key markets, and connections to a wide network of industry leaders, partners, and potential customers. Draper Dragon's portfolio companies benefit from the firm’s deep expertise in both venture investing and cross-border expansion, enabling them to scale quickly and efficiently in multiple regions. Draper Dragon focuses on disruptive technologies that have the potential to create significant market shifts and drive innovation on a global scale. By identifying and backing visionary entrepreneurs, the firm seeks to foster long-term growth and success in its investments. Its proactive approach, combined with a strong emphasis on fostering partnerships between the East and the West, makes Draper Dragon a crucial player in the venture capital landscape. With a track record of successful investments and a commitment to helping startups thrive globally, Draper Dragon continues to be a trusted partner for entrepreneurs seeking to build industry-leading companies.

The Drawdown Fund is a growth equity investment firm focused on businesses that address the key drivers of climate change. Co-founded by the renowned environmentalist Paul Hawken, the fund leverages robust climate models and research to guide its investment strategy. The Drawdown Fund targets companies that have proven technology, established revenue, strong growth, and a clear competitive advantage, typically investing between $10 million and $30 million. The fund is particularly interested in companies that are actively reducing carbon emissions or sequestering greenhouse gases. Their investment focus spans three major systems: Energy Transition, Resilient Systems, and Sustainable Cities. These sectors include technologies like smart grids, renewable energy, sustainable food and agriculture, and urban decarbonization. The Drawdown Fund prides itself on its deep industry knowledge and a strong network of operators, entrepreneurs, and researchers who provide value beyond capital. The team has over 50 years of combined experience in sustainability and growth investing, ensuring a hands-on approach with each portfolio company. They also maintain a low partner-to-portfolio company ratio, allowing for tailored support and active governance. This strategy is tightly aligned with the fund’s mission to generate both financial returns and significant positive impacts on global warming, with management carry incentives directly tied to emissions reductions or sequestration. This makes the Drawdown Fund a compelling partner for companies focused on sustainability and climate solutions.

Dream Ventures is a Las Vegas-based venture capital firm, founded in 2022, with a focus on supporting visionary entrepreneurs in building disruptive, high-growth companies. The firm primarily invests in industries driving future innovation, such as decentralized finance (DeFi), NFTs, blockchain gaming, and Web3 applications. By backing startups in early stages, Dream Ventures positions itself at the cutting edge of technological advancements and business transformation. Their portfolio includes notable investments in companies like Marlow and ChargeFuze, with a strong emphasis on personal products, B2C services, and business software. Dream Ventures is known for its flexible check sizes, ranging from early-stage funding to significant growth capital. The firm also runs a female-focused accelerator, connecting women-led businesses with top-tier investors. Dream Ventures prides itself on fostering a collaborative environment, helping female founders secure deals with major corporations such as Amex and Sephora. Founders can reach out through their accelerator or investment application processes to tap into Dream Ventures’ extensive network and strategic support. Led by partners such as Sampson Simmons and Eric Wong, Dream Ventures actively co-invests with reputable firms like Bain Capital and Goodwater Capital, offering both capital and expertise to help their portfolio companies scale and succeed.

Dreamcraft Ventures, founded in 2019 and based in Copenhagen, Denmark, is an early-stage venture capital firm focused on investing in tech-driven startups across the Nordics and Europe. With a strong emphasis on industries like gaming, esports, B2B SaaS, digital entertainment, and fintech, Dreamcraft has developed a hands-on approach to supporting founders from seed to Series A. The firm refers to itself as "venture engineers," offering operational support and strategic guidance to help companies scale. Dreamcraft has a strong generalist investment strategy, reflected in its diverse portfolio that includes companies like Hiber, a social entertainment platform, and GRID, which leverages esports data assets. The firm raised €66 million for its second fund, Dreamcraft Fund II, and continues to actively invest in early-stage companies with a focus on helping them grow into category leaders. Founded by Jesper Søgaard and Christian Kirk Rasmussen, who built Better Collective into a billion-dollar company, Dreamcraft brings founder experience to the table, focusing on high-quality teams and long-term partnerships.

Dreamers VC, founded by Will Smith and Keisuke Honda, is a venture capital firm based in Los Angeles, focusing on early-stage investments across various sectors including health biotech, finance tech, consumer products, and entertainment. Since its inception, Dreamers VC has built a diverse portfolio of innovative companies. Their notable investments include Beam Therapeutics, which is pioneering precision genetic medicines; Nurx, providing personalized healthcare solutions delivered directly to consumers; and Sandbox VR, offering immersive group virtual reality experiences. Other significant investments include HomeCourt, a basketball training app, and Public, a platform for investing in crypto assets. Dreamers VC emphasizes community and leveraging their global network to connect founders with valuable resources. Their approach combines financial support with strategic guidance, ensuring startups have the tools they need to grow and succeed in competitive markets.